Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,602 public trials 545 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Active, Not Recruiting

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

NCT03896737

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease, +15 more
Locations
  • Hradec Kralove-University Hospital Hradec Kralove Hradec Králové, Czechia
  • University Hospital Olomouc Olomouc, Czechia
  • University Hospital Ostrava Ostrava, Czechia
  • University Hospital Ostrava Ostrava, Czechia
View all 24 locations
View Trial Details
Active, Not Recruiting

Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients

NCT04564703

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Centre Hospitalier Universitaire de Bordeaux Bordeau, France
  • Centre Hospitalier Universitaire de Dijon Dijon, France
  • CHU Hôtel-Dieu, 1, place Alexis Ricordeau, 44093 NANTES Cedex 1, FRANCE Nantes, France
  • CHU Hôtel-Dieu Nantes, France
View all 22 locations
View Trial Details
Active, Not Recruiting

Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

NCT04483739

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Het Ziekenhuisnetwerk Antwerpen - Department of Hematology Antwerp, Belgium
  • Fakultni Nemocnice Brno - Internal Hematology and Oncology Clinic Brno, Czechia
  • Fakultni Nemocnice Hradec Kralove - 4th Department of Internal Medicine Nový Hradec Králové, Czechia
  • Fakultni Nemocnice Ostrava - Department of Haematooncology Ostrava, Czechia
View all 41 locations
View Trial Details
Active, Not Recruiting

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

NCT04754945

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • University of California Orange, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis

NCT06097832

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Sutter Health Alta Bates Berkeley, California, United States
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Venetoclax-Dexamethasone in Relapsed and/or Refractory t(11;14) Amyloidosis

NCT05451771

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Boston Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • New York Presbyterian Hospital/Columbia University Irving Medical Center New York, United States
View Trial Details

Related conditions